Xuemin Gu, Ph.D. - Publications
Affiliations: | 2012 | Biostatistics | The University of Texas School of Public Health |
Area:
Biostatistics BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2016 | Gu X, Chen N, Wei C, Liu S, Papadimitrakopoulou VA, Herbst RS, Lee JJ. Bayesian Two-stage Biomarker-based Adaptive Design for Targeted Therapy Development. Statistics in Biosciences. 8: 99-128. PMID 27617040 DOI: 10.1007/s12561-014-9124-2 | 0.432 | |||
2013 | Gu X, Yin G, Lee JJ. Bayesian two-step Lasso strategy for biomarker selection in personalized medicine development for time-to-event endpoints. Contemporary Clinical Trials. 36: 642-50. PMID 24075829 DOI: 10.1016/J.Cct.2013.09.009 | 0.421 | |||
2011 | Kadara H, Behrens C, Yuan P, Solis L, Liu D, Gu X, Minna JD, Lee JJ, Kim E, Hong WK, Wistuba II, Lotan R. A five-gene and corresponding protein signature for stage-I lung adenocarcinoma prognosis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 1490-501. PMID 21163870 DOI: 10.1158/1078-0432.Ccr-10-2703 | 0.421 | |||
2010 | Gu X, Lee JJ. A simulation study for comparing testing statistics in response-adaptive randomization. Bmc Medical Research Methodology. 10: 48. PMID 20525382 DOI: 10.1186/1471-2288-10-48 | 0.372 | |||
2009 | Kadara H, Lacroix L, Behrens C, Solis L, Gu X, Lee JJ, Tahara E, Lotan D, Hong WK, Wistuba II, Lotan R. Identification of gene signatures and molecular markers for human lung cancer prognosis using an in vitro lung carcinogenesis system. Cancer Prevention Research (Philadelphia, Pa.). 2: 702-11. PMID 19638491 DOI: 10.1158/1940-6207.Capr-09-0084 | 0.431 | |||
Show low-probability matches. |